关注
arnaud dupuis
arnaud dupuis
Etablissement Français du sang, INSERM UMR 1255
在 efs.sante.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Immobilized fibrinogen activates human platelets through glycoprotein VI
PH Mangin, MB Onselaer, N Receveur, N Le Lay, AT Hardy, C Wilson, ...
haematologica 103 (5), 898, 2018
1442018
Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia
P Kastner, A Dupuis, MP Gaub, R Herbrecht, P Lutz, S Chan
American journal of blood research 3 (1), 1, 2013
872013
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC
P Gresele, S Orsini, P Noris, E Falcinelli, MC Alessi, L Bury, M Borhany, ...
Journal of Thrombosis and Haemostasis 18 (3), 732-739, 2020
842020
Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations
A Dupuis, MP Gaub, M Legrain, B Drenou, L Mauvieux, P Lutz, ...
Leukemia 27 (2), 503-507, 2013
822013
Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects
B Hechler, A Dupuis, PH Mangin, C Gachet
Research and practice in thrombosis and haemostasis 3 (4), 615-625, 2019
602019
Identification of a new dysfunctional platelet P2Y12 receptor variant associated with bleeding diathesis
A Lecchi, C Razzari, S Paoletta, A Dupuis, L Nakamura, P Ohlmann, ...
Blood, The Journal of the American Society of Hematology 125 (6), 1006-1013, 2015
552015
Platelet δ-storage pool disease: an update
A Dupuis, JC Bordet, A Eckly, C Gachet
Journal of clinical medicine 9 (8), 2508, 2020
542020
An essential role for α4A-tubulin in platelet biogenesis
C Strassel, MM Magiera, A Dupuis, M Batzenschlager, A Hovasse, ...
Life science alliance 2 (1), 2019
452019
Inherited platelet disorders: Management of the bleeding risk
A Dupuis, C Gachet
Transfusion Clinique et Biologique 25 (3), 228-235, 2018
302018
Cell surface expression of HLA I molecules as a marker of young platelets
C Angénieux, A Dupuis, C Gachet, H de la Salle, B Maître
Journal of Thrombosis and Haemostasis 17 (9), 1511-1521, 2019
272019
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology
P Gresele, E Falcinelli, L Bury, A Pecci, MC Alessi, M Borhany, PG Heller, ...
Journal of Thrombosis and Haemostasis 19 (5), 1364-1371, 2021
262021
Inherited dysfunctional platelet P2Y12 receptor mutations associated with bleeding disorders
A Lecchi, EA Femia, S Paoletta, A Dupuis, P Ohlmann, C Gachet, ...
Haemostaseologie 36 (04), 279-283, 2016
222016
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study
F Paciullo, L Bury, P Noris, E Falcinelli, F Melazzini, S Orsini, C Zaninetti, ...
haematologica 105 (7), 1948, 2020
122020
The contribution of mouse models to the understanding of constitutional thrombocytopenia
C Léon, A Dupuis, C Gachet, F Lanza
haematologica 101 (8), 896, 2016
112016
Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis
C Strassel, L Kubovcakova, PH Mangin, C Ravanat, M Freund, RC Skoda, ...
Thrombosis and Haemostasis 114 (02), 414-425, 2015
112015
A novel platelet-type von Willebrand disease mutation (GP1BA p. Met255Ile) associated with type 2B “Malmö/New York” von Willebrand disease
C Lavenu-Bombled, C Guitton, A Dupuis, MJ Baas, C Desconclois, ...
Thrombosis and Haemostasis 116 (12), 1070-1078, 2016
102016
High prevalence of the natural Asn89Asp mutation in the GP1BB gene associated with Bernard–Soulier syndrome in French patients from the genetic isolate of Reunion Island
M Fiore, C De Thoré, H Randrianaivo-Ranjatoelina, MJ Baas, ...
British journal of haematology 189 (3), e67, 2020
82020
In vitro quality of amotosalen‐UVA pathogen‐inactivated mini‐pool plasma prepared from whole blood stored overnight
C Ravanat, A Dupuis, N Marpaux, C Naegelen, G Mourey, H Isola, ...
Vox Sanguinis 113 (7), 622-631, 2018
72018
Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects
A Couvidou, G Rojas-Jiménez, A Dupuis, B Maître
Frontiers in Immunology 14, 1125367, 2023
62023
Pathogenic and likely pathogenic variants in at least five genes account for approximately 3% of mild isolated nonsyndromic thrombocytopenia
P Guéguen, A Dupuis, JY Py, A Desprès, E Masson, C Le Marechal, ...
Transfusion 60 (10), 2419-2431, 2020
62020
系统目前无法执行此操作,请稍后再试。
文章 1–20